SCYNEXIS Inc (SCYX)
1.46
+0.04
(+2.82%)
USD |
NASDAQ |
Apr 18, 11:36
SCYNEXIS Cash and Short Term Investments (Quarterly): 74.36M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 74.36M |
| September 30, 2023 | 88.07M |
| June 30, 2023 | 85.54M |
| March 31, 2023 | 54.82M |
| December 31, 2022 | 73.50M |
| September 30, 2022 | 96.09M |
| June 30, 2022 | 118.69M |
| March 31, 2022 | 95.21M |
| December 31, 2021 | 104.48M |
| September 30, 2021 | 100.11M |
| June 30, 2021 | 112.44M |
| March 31, 2021 | 92.01M |
| December 31, 2020 | 93.04M |
| September 30, 2020 | 29.49M |
| June 30, 2020 | 37.62M |
| March 31, 2020 | 34.52M |
| December 31, 2019 | 48.41M |
| September 30, 2019 | 28.11M |
| June 30, 2019 | 35.23M |
| March 31, 2019 | 39.06M |
| December 31, 2018 | 44.16M |
| Date | Value |
|---|---|
| September 30, 2018 | 49.49M |
| June 30, 2018 | 55.19M |
| March 31, 2018 | 63.70M |
| December 31, 2017 | 43.89M |
| September 30, 2017 | 47.71M |
| June 30, 2017 | 49.34M |
| March 31, 2017 | 54.90M |
| December 31, 2016 | 58.59M |
| September 30, 2016 | 52.35M |
| June 30, 2016 | 50.34M |
| March 31, 2016 | 38.02M |
| December 31, 2015 | 46.98M |
| September 30, 2015 | 53.77M |
| June 30, 2015 | 57.06M |
| March 31, 2015 | 27.62M |
| December 31, 2014 | 32.24M |
| September 30, 2014 | 34.04M |
| June 30, 2014 | 38.42M |
| March 31, 2014 | 0.65M |
| December 31, 2013 | 1.402M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
28.11M
Minimum
Sep 2019
118.69M
Maximum
Jun 2022
73.78M
Average
85.54M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.13M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |
| Theriva Biologics Inc | 23.18M |
| Ampio Pharmaceuticals Inc | 4.089M |